Amphotericin B lipid complex for neonatal invasive candidiasis
- PMID: 11207232
- PMCID: PMC1721216
- DOI: 10.1136/fn.84.2.f131
Amphotericin B lipid complex for neonatal invasive candidiasis
Abstract
This study describes the safety and efficacy of amphotericin B lipid complex (ABLC) in 11 neonates with systemic Candida infections. Nine of the 11 improved clinically, and eight of nine evaluable patients had a mycological cure with ABLC. Creatinine levels improved or did not significantly change in eight of the 11 patients.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical